Behavioural pharmacology of glutamate receptors in the basal ganglia (Q41509236)

1 October 2017

1 reference

title

Behavioural pharmacology of glutamate receptors in the basal ganglia (English)

1 reference

1 October 2017

1 reference

Schmidt WJ

1 reference

1 October 2017

Kretschmer BD

series ordinal

1 reference

1 October 2017

publication date

1 July 1997

1 reference

Neuroscience & Biobehavioral Reviews

1 October 2017

published in

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

381-392

1 reference

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Structural requirements for the development of potent n-methyl-d-aspartic acid (NMDA) receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Prefrontal Corticostriatal Afferents Maintain Increased Enkephalin Gene Expression in the Dopamine-denervated Rat Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Motor activity induced by disinhibition of the primary motor cortex of the rat is blocked by a non-NMDA glutamate receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The pharmacological and anatomical substrates of the amphetamine response in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glycine and D-serine increase the affinity of N-methyl-D-aspartate sensitive glutamate binding sites in rat brain synaptic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Discrete quinolinic acid lesions of the lateral but not of the medial caudate-putamen reversed haloperidol-induced catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Enhanced amphetamine responses after frontal cortex lesions in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist‐sensitive sites in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Behavioral effects of non-NMDA glutamate receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

In vivo voltammetric investigations into the action of HA-966 on central dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Hyperactivity induced by N-methyl-d-aspartate injections into nucleus accumbens: lack of evidence for mediation by dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

In vivo demonstration of the enhancement of MK-801 by L-glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Are N- methyl- d -aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Neurochemical Interactions of Competitive N-Methyl-D-Aspartate Antagonists with Dopaminergic Neurotransmission and the Cerebellar Cyclic GMP System: Functional Evidence for a Phasic Glutamatergic Control of the Nigrostriatal Dopaminergic Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Drug-induced parkinsonism and other movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Regionally distinct N-methyl-D-aspartate receptors distinguished by quantitative autoradiography of [3H]MK-801 binding in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The catalepsy test: its ups and downs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Cortical modulation of striatal function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Anticataleptic potencies of glutamate-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Metabotropic glutamate receptors in brain function and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glutamate stimulates inositol phosphate formation in striatal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Induction of feeding by 7-chlorokynurenic acid, a strychnine-insensitive glycine binding site antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: an electrochemical and behavioural study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Modulation of glutamate receptors: molecular mechanisms and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glutamate receptor expression in rat striatum: effect of deafferentation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Lesions of the entopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900044-9

7 January 2021

10.1016/S0149-7634(96)00044-9

Identifiers

DOI

1 reference

1 October 2017

1 reference